Apollomics Inc. (APLM) SEC Filings & Financial Intelligence
Apollomics Inc. (APLM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: APLM
CIK: 1944885
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Marcum Asia CPAs LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerHsin Hui Chiang
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4/A | 2026-09-24 | 2026-09-14 | 4/A | 0001193125-26-401341 | View SEC Doc Filr Page |
| 4/A | 2026-09-24 | 2026-09-14 | 4/A | 0001193125-26-401336 | View SEC Doc Filr Page |
| 4/A | 2026-09-24 | 2026-09-14 | 4/A | 0001193125-26-401335 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-14 | 4 | 0001193125-26-394809 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-14 | 4 | 0001193125-26-394805 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-14 | 4 | 0001193125-26-394803 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-14 | 4 | 0001193125-26-394802 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-14 | 4 | 0001193125-26-394796 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-14 | 4 | 0001193125-26-394794 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-14 | 4 | 0001193125-26-394786 | View SEC Doc Filr Page |
| 424B3 | 2026-09-08 | — | 424B3 | 0001193125-26-384280 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-17 | 4 | 0001193125-26-363943 | View SEC Doc Filr Page |
| D | 2026-08-19 | — | D Filing | 0001193125-26-355924 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | 4 | 0001193125-26-354470 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | 4 | 0001193125-26-354465 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | 4 | 0001193125-26-354457 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-17 | — | SCHEDULE 13D/A Filing | 0001193125-26-354020 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-14 | — | SCHEDULE 13D/A Filing | 0001213900-26-090085 | View SEC Doc Filr Page |
| 6-K | 2026-08-12 | 2026-08-11 | 6-K | 0001193125-26-345197 | View SEC Doc Filr Page |
| 3 | 2026-07-24 | 2026-07-20 | 3 | 0001193125-26-316489 | View SEC Doc Filr Page |
| 6-K | 2026-07-21 | 2026-07-21 | 6-K | 0001193125-26-310154 | View SEC Doc Filr Page |
| 6-K | 2026-07-14 | 2026-07-14 | 6-K | 0001193125-26-302494 | View SEC Doc Filr Page |
| 6-K | 2026-06-24 | 2026-06-24 | 6-K | 0001193125-26-281262 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274552 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-15 | 4 | 0001193125-26-272860 | View SEC Doc Filr Page |